BioScience Health Innovations (BHIC) Other Accumulated Expenses (2021 - 2025)
Historic Other Accumulated Expenses for BioScience Health Innovations (BHIC) over the last 5 years, with Q3 2025 value amounting to $228298.0.
- BioScience Health Innovations' Other Accumulated Expenses rose 55982.08% to $228298.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $228298.0, marking a year-over-year increase of 55982.08%. This contributed to the annual value of $87074.0 for FY2023, which is 9197.9% up from last year.
- As of Q3 2025, BioScience Health Innovations' Other Accumulated Expenses stood at $228298.0, which was up 55982.08% from $47837.0 recorded in Q2 2025.
- In the past 5 years, BioScience Health Innovations' Other Accumulated Expenses ranged from a high of $228298.0 in Q3 2025 and a low of $404.0 during Q1 2022
- Over the past 5 years, BioScience Health Innovations' median Other Accumulated Expenses value was $46777.5 (recorded in 2025), while the average stood at $65806.8.
- As far as peak fluctuations go, BioScience Health Innovations' Other Accumulated Expenses plummeted by 8667.62% in 2024, and later surged by 55982.08% in 2025.
- Quarter analysis of 5 years shows BioScience Health Innovations' Other Accumulated Expenses stood at $625.0 in 2021, then plummeted by 35.36% to $404.0 in 2022, then skyrocketed by 21452.97% to $87074.0 in 2023, then crashed by 60.26% to $34600.0 in 2024, then soared by 559.82% to $228298.0 in 2025.
- Its Other Accumulated Expenses stands at $228298.0 for Q3 2025, versus $47837.0 for Q2 2025 and $45718.0 for Q1 2025.